Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

POU domain, class 3, transcription factor 2 (Brain-specific homeobox/POU domain protein 2) (Brain-2) (Brn-2) (Nervous system-specific octamer-binding transcription factor N-Oct-3) (Octamer-binding protein 7) (Oct-7) (Octamer-binding transcription factor 7) (OTF-7)

 PO3F2_HUMAN             Reviewed;         443 AA.
P20265; Q14960; Q86V54; Q9UJL0;
01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
13-SEP-2005, sequence version 4.
12-SEP-2018, entry version 191.
RecName: Full=POU domain, class 3, transcription factor 2;
AltName: Full=Brain-specific homeobox/POU domain protein 2;
Short=Brain-2;
Short=Brn-2;
AltName: Full=Nervous system-specific octamer-binding transcription factor N-Oct-3;
AltName: Full=Octamer-binding protein 7;
Short=Oct-7;
AltName: Full=Octamer-binding transcription factor 7;
Short=OTF-7;
Name=POU3F2; Synonyms=BRN2, OCT7, OTF7;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Brain;
PubMed=8441633; DOI=10.1093/nar/21.2.253;
Schreiber E., Tobler A., Malipiero U., Schaffner W., Fontana A.;
"cDNA cloning of human N-Oct3, a nervous-system specific POU domain
transcription factor binding to the octamer DNA motif.";
Nucleic Acids Res. 21:253-258(1993).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
TISSUE=Liver;
PubMed=7651733;
Angus J., Thomson F., Murphy K., Baker E., Sutherland G.R.,
Parsons P.G., Sturm R.A.;
"The brn-2 gene regulates the melanocytic phenotype and tumorigenic
potential of human melanoma cells.";
Oncogene 11:691-700(1995).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=14574404; DOI=10.1038/nature02055;
Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
"The DNA sequence and analysis of human chromosome 6.";
Nature 425:805-811(2003).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
NUCLEOTIDE SEQUENCE [MRNA] OF 280-404.
TISSUE=Brain;
PubMed=2739723; DOI=10.1038/340035a0;
He X., Treacy M.N., Simmons D.M., Ingraham H.A., Swanson L.W.,
Rosenfeld M.G.;
"Expression of a large family of POU-domain regulatory genes in
mammalian brain development.";
Nature 340:35-42(1989).
[6]
INTERACTION WITH PQBP1.
TISSUE=Brain;
PubMed=10332029; DOI=10.1093/hmg/8.6.977;
Waragai M., Lammers C.-H., Takeuchi S., Imafuku I., Udagawa Y.,
Kanazawa I., Kawabata M., Mouradian M.M., Okazawa H.;
"PQBP-1, a novel polyglutamine tract binding protein, inhibits
transcription activation by Brn-2 and affects cell survival.";
Hum. Mol. Genet. 8:977-987(1999).
[7]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19413330; DOI=10.1021/ac9004309;
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
Mohammed S.;
"Lys-N and trypsin cover complementary parts of the phosphoproteome in
a refined SCX-based approach.";
Anal. Chem. 81:4493-4501(2009).
[8]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Leukemic T-cell;
PubMed=19690332; DOI=10.1126/scisignal.2000007;
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
Rodionov V., Han D.K.;
"Quantitative phosphoproteomic analysis of T cell receptor signaling
reveals system-wide modulation of protein-protein interactions.";
Sci. Signal. 2:RA46-RA46(2009).
[9]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
-!- FUNCTION: Transcription factor that plays a key role in neuronal
differentiation (By similarity). Binds preferentially to the
recognition sequence which consists of two distinct half-sites,
('GCAT') and ('TAAT'), separated by a non-conserved spacer region
of 0, 2, or 3 nucleotides (By similarity). The combination of
three transcription factors, ASCL1, POU3F2/BRN2 and MYT1L, is
sufficient to reprogram fibroblasts and other somatic cells into
induced neuronal (iN) cells in vitro. Acts downstream of ASCL1,
accessing chromatin that has been opened by ASCL1, and promotes
transcription of neuronal genes (By similarity).
{ECO:0000250|UniProtKB:P31360, ECO:0000250|UniProtKB:P56222}.
-!- SUBUNIT: Interacts with PQBP1 (PubMed:10332029). Interaction with
ISL1 (By similarity). {ECO:0000250|UniProtKB:P31360,
ECO:0000269|PubMed:10332029}.
-!- INTERACTION:
Self; NbExp=2; IntAct=EBI-1167176, EBI-1167176;
Q09472:EP300; NbExp=3; IntAct=EBI-1167176, EBI-447295;
P23760:PAX3; NbExp=2; IntAct=EBI-1167176, EBI-1167564;
P56693:SOX10; NbExp=3; IntAct=EBI-1167176, EBI-1167533;
P20226:TBP; NbExp=2; IntAct=EBI-1167176, EBI-355371;
-!- SUBCELLULAR LOCATION: Nucleus.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative initiation; Named isoforms=3;
Name=N-OCT 3;
IsoId=P20265-1; Sequence=Displayed;
Name=N-OCT 5A;
IsoId=P20265-2; Sequence=VSP_018749;
Name=N-OCT 5B;
IsoId=P20265-3; Sequence=VSP_018750;
-!- TISSUE SPECIFICITY: Expressed specifically in the neuroectodermal
cell lineage.
-!- SIMILARITY: Belongs to the POU transcription factor family. Class-
3 subfamily. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; Z11933; CAA77990.1; -; mRNA.
EMBL; L37868; AAB59611.1; -; Genomic_DNA.
EMBL; AL022395; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC051699; AAH51699.2; -; mRNA.
CCDS; CCDS5040.1; -. [P20265-1]
PIR; S29334; S29334.
RefSeq; NP_005595.2; NM_005604.3. [P20265-1]
UniGene; Hs.182505; -.
ProteinModelPortal; P20265; -.
SMR; P20265; -.
BioGrid; 111450; 8.
IntAct; P20265; 6.
STRING; 9606.ENSP00000329170; -.
BindingDB; P20265; -.
ChEMBL; CHEMBL4189; -.
iPTMnet; P20265; -.
PhosphoSitePlus; P20265; -.
BioMuta; POU3F2; -.
DMDM; 78100757; -.
EPD; P20265; -.
MaxQB; P20265; -.
PaxDb; P20265; -.
PeptideAtlas; P20265; -.
PRIDE; P20265; -.
ProteomicsDB; 53737; -.
ProteomicsDB; 53738; -. [P20265-2]
ProteomicsDB; 53739; -. [P20265-3]
Ensembl; ENST00000328345; ENSP00000329170; ENSG00000184486. [P20265-1]
GeneID; 5454; -.
KEGG; hsa:5454; -.
UCSC; uc003ppe.4; human. [P20265-1]
CTD; 5454; -.
DisGeNET; 5454; -.
EuPathDB; HostDB:ENSG00000184486.8; -.
GeneCards; POU3F2; -.
HGNC; HGNC:9215; POU3F2.
HPA; HPA047081; -.
HPA; HPA056261; -.
MIM; 600494; gene.
neXtProt; NX_P20265; -.
OpenTargets; ENSG00000184486; -.
PharmGKB; PA33539; -.
eggNOG; KOG3802; Eukaryota.
eggNOG; ENOG410XQ7X; LUCA.
GeneTree; ENSGT00760000118935; -.
HOGENOM; HOG000116303; -.
HOVERGEN; HBG053120; -.
InParanoid; P20265; -.
KO; K09365; -.
OMA; SFTVNGM; -.
OrthoDB; EOG091G0U0S; -.
PhylomeDB; P20265; -.
TreeFam; TF316413; -.
SignaLink; P20265; -.
SIGNOR; P20265; -.
ChiTaRS; POU3F2; human.
GeneWiki; POU3F2; -.
GenomeRNAi; 5454; -.
PRO; PR:P20265; -.
Proteomes; UP000005640; Chromosome 6.
Bgee; ENSG00000184486; Expressed in 72 organ(s), highest expression level in cerebral cortex.
CleanEx; HS_POU3F2; -.
Genevisible; P20265; HS.
GO; GO:0005634; C:nucleus; IDA:HPA.
GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
GO; GO:0042802; F:identical protein binding; IPI:IntAct.
GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB.
GO; GO:0003713; F:transcription coactivator activity; IEA:Ensembl.
GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
GO; GO:0014002; P:astrocyte development; IEA:Ensembl.
GO; GO:0071310; P:cellular response to organic substance; IEA:Ensembl.
GO; GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl.
GO; GO:0008544; P:epidermis development; IEA:Ensembl.
GO; GO:0021869; P:forebrain ventricular zone progenitor cell division; IEA:Ensembl.
GO; GO:0021979; P:hypothalamus cell differentiation; IEA:Ensembl.
GO; GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl.
GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
GO; GO:0021985; P:neurohypophysis development; IEA:Ensembl.
GO; GO:0048666; P:neuron development; ISS:UniProtKB.
GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
GO; GO:0048663; P:neuron fate commitment; ISS:UniProtKB.
GO; GO:0048665; P:neuron fate specification; ISS:UniProtKB.
GO; GO:0008284; P:positive regulation of cell proliferation; IDA:MGI.
GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
GO; GO:0050770; P:regulation of axonogenesis; IEA:Ensembl.
GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISS:UniProtKB.
CDD; cd00086; homeodomain; 1.
InterPro; IPR009057; Homeobox-like_sf.
InterPro; IPR017970; Homeobox_CS.
InterPro; IPR001356; Homeobox_dom.
InterPro; IPR010982; Lambda_DNA-bd_dom_sf.
InterPro; IPR013847; POU.
InterPro; IPR000327; POU_dom.
InterPro; IPR016362; TF_POU_3.
Pfam; PF00046; Homeobox; 1.
Pfam; PF00157; Pou; 1.
PIRSF; PIRSF002629; Transcription_factor_POU; 1.
PRINTS; PR00028; POUDOMAIN.
SMART; SM00389; HOX; 1.
SMART; SM00352; POU; 1.
SUPFAM; SSF46689; SSF46689; 1.
SUPFAM; SSF47413; SSF47413; 1.
PROSITE; PS00027; HOMEOBOX_1; 1.
PROSITE; PS50071; HOMEOBOX_2; 1.
PROSITE; PS00035; POU_1; 1.
PROSITE; PS00465; POU_2; 1.
PROSITE; PS51179; POU_3; 1.
1: Evidence at protein level;
Activator; Alternative initiation; Complete proteome; Differentiation;
DNA-binding; Homeobox; Neurogenesis; Nucleus; Phosphoprotein;
Reference proteome; Transcription; Transcription regulation.
CHAIN 1 443 POU domain, class 3, transcription factor
2.
/FTId=PRO_0000013495.
DOMAIN 262 336 POU-specific. {ECO:0000255|PROSITE-
ProRule:PRU00530}.
DNA_BIND 354 413 Homeobox. {ECO:0000255|PROSITE-
ProRule:PRU00108}.
COMPBIAS 68 90 Poly-Gly.
COMPBIAS 125 149 Poly-Gln.
MOD_RES 341 341 Phosphoserine.
{ECO:0000244|PubMed:19690332}.
VAR_SEQ 1 199 Missing (in isoform N-OCT 5B).
{ECO:0000305}.
/FTId=VSP_018750.
VAR_SEQ 1 180 Missing (in isoform N-OCT 5A).
{ECO:0000305}.
/FTId=VSP_018749.
CONFLICT 26 26 G -> A (in Ref. 1; CAA77990).
{ECO:0000305}.
CONFLICT 170 170 S -> T (in Ref. 1 and 2). {ECO:0000305}.
CONFLICT 207 207 P -> S (in Ref. 4; AAH51699).
{ECO:0000305}.
SEQUENCE 443 AA; 46893 MW; D470360894D788C6 CRC64;
MATAASNHYS LLTSSASIVH AEPPGGMQQG AGGYREAQSL VQGDYGALQS NGHPLSHAHQ
WITALSHGGG GGGGGGGGGG GGGGGGGGDG SPWSTSPLGQ PDIKPSVVVQ QGGRGDELHG
PGALQQQHQQ QQQQQQQQQQ QQQQQQQQQR PPHLVHHAAN HHPGPGAWRS AAAAAHLPPS
MGASNGGLLY SQPSFTVNGM LGAGGQPAGL HHHGLRDAHD EPHHADHHPH PHSHPHQQPP
PPPPPQGPPG HPGAHHDPHS DEDTPTSDDL EQFAKQFKQR RIKLGFTQAD VGLALGTLYG
NVFSQTTICR FEALQLSFKN MCKLKPLLNK WLEEADSSSG SPTSIDKIAA QGRKRKKRTS
IEVSVKGALE SHFLKCPKPS AQEITSLADS LQLEKEVVRV WFCNRRQKEK RMTPPGGTLP
GAEDVYGGSR DTPPHHGVQT PVQ


Related products :

Catalog number Product name Quantity
U1614r CLIA Brain-2,Brain-specific homeobox_POU domain protein 2,Brn2,Brn-2,Nervous system-specific octamer-binding transcription factor N-Oct-3,Oct-7,Octamer-binding protein 7,Octamer-binding transcription 96T
E1614r ELISA Brain-2,Brain-specific homeobox_POU domain protein 2,Brn2,Brn-2,Nervous system-specific octamer-binding transcription factor N-Oct-3,Oct-7,Octamer-binding protein 7,Octamer-binding transcription 96T
E1614r ELISA kit Brain-2,Brain-specific homeobox_POU domain protein 2,Brn2,Brn-2,Nervous system-specific octamer-binding transcription factor N-Oct-3,Oct-7,Octamer-binding protein 7,Octamer-binding transcri 96T
U1614m CLIA Brain-2,Brain-specific homeobox_POU domain protein 2,Brn2,Brn-2,Brn-2,Mouse,Mus musculus,Nervous system-specific octamer-binding transcription factor N-Oct-3,Oct-7,Octamer-binding protein 7,Octam 96T
E1614m ELISA Brain-2,Brain-specific homeobox_POU domain protein 2,Brn2,Brn-2,Brn-2,Mouse,Mus musculus,Nervous system-specific octamer-binding transcription factor N-Oct-3,Oct-7,Octamer-binding protein 7,Octa 96T
E1614h ELISA kit Brain-2,Brain-specific homeobox_POU domain protein 2,BRN2,Brn-2,Homo sapiens,Human,Nervous system-specific octamer-binding transcription factor N-Oct-3,OCT7,Oct-7,Octamer-binding protein 7, 96T
E1614m ELISA kit Brain-2,Brain-specific homeobox_POU domain protein 2,Brn2,Brn-2,Brn-2,Mouse,Mus musculus,Nervous system-specific octamer-binding transcription factor N-Oct-3,Oct-7,Octamer-binding protein 7 96T
U1614h CLIA Brain-2,Brain-specific homeobox_POU domain protein 2,BRN2,Brn-2,Homo sapiens,Human,Nervous system-specific octamer-binding transcription factor N-Oct-3,OCT7,Oct-7,Octamer-binding protein 7,Octame 96T
E1614h ELISA Brain-2,Brain-specific homeobox_POU domain protein 2,BRN2,Brn-2,Homo sapiens,Human,Nervous system-specific octamer-binding transcription factor N-Oct-3,OCT7,Oct-7,Octamer-binding protein 7,Octam 96T
U1643r CLIA Brain-4,Brain-specific homeobox_POU domain protein 4,Brn4,Brn-4,Brn-4,Oct-9,Octamer-binding protein 9,Octamer-binding transcription factor 9,Otf9,OTF-9,POU domain, class 3, transcription factor 4 96T
E1643r ELISA Brain-4,Brain-specific homeobox_POU domain protein 4,Brn4,Brn-4,Brn-4,Oct-9,Octamer-binding protein 9,Octamer-binding transcription factor 9,Otf9,OTF-9,POU domain, class 3, transcription factor 96T
E1643r ELISA kit Brain-4,Brain-specific homeobox_POU domain protein 4,Brn4,Brn-4,Brn-4,Oct-9,Octamer-binding protein 9,Octamer-binding transcription factor 9,Otf9,OTF-9,POU domain, class 3, transcription fa 96T
E1616h ELISA kit Brain-1,Brain-specific homeobox_POU domain protein 1,BRN1,Brn-1,Homo sapiens,Human,Oct-8,Octamer-binding protein 8,Octamer-binding transcription factor 8,OTF8,OTF-8,POU domain, class 3, tra 96T
E1643h ELISA kit Brain-4,Brain-specific homeobox_POU domain protein 4,BRN4,Brn-4,Homo sapiens,Human,Oct-9,Octamer-binding protein 9,Octamer-binding transcription factor 9,OTF9,OTF-9,POU domain, class 3, tra 96T
E1616h ELISA Brain-1,Brain-specific homeobox_POU domain protein 1,BRN1,Brn-1,Homo sapiens,Human,Oct-8,Octamer-binding protein 8,Octamer-binding transcription factor 8,OTF8,OTF-8,POU domain, class 3, transcri 96T
E1643h ELISA Brain-4,Brain-specific homeobox_POU domain protein 4,BRN4,Brn-4,Homo sapiens,Human,Oct-9,Octamer-binding protein 9,Octamer-binding transcription factor 9,OTF9,OTF-9,POU domain, class 3, transcri 96T
U1643h CLIA Brain-4,Brain-specific homeobox_POU domain protein 4,BRN4,Brn-4,Homo sapiens,Human,Oct-9,Octamer-binding protein 9,Octamer-binding transcription factor 9,OTF9,OTF-9,POU domain, class 3, transcrip 96T
U1616h CLIA Brain-1,Brain-specific homeobox_POU domain protein 1,BRN1,Brn-1,Homo sapiens,Human,Oct-8,Octamer-binding protein 8,Octamer-binding transcription factor 8,OTF8,OTF-8,POU domain, class 3, transcrip 96T
E1616m ELISA kit Brain-1,Brain-specific homeobox_POU domain protein 1,Brn1,Brn-1,Brn-1,Mouse,Mus musculus,Oct-8,Octamer-binding protein 8,Octamer-binding transcription factor 8,Otf8,OTF-8,POU domain, class 96T
E1643m ELISA kit Brain-4,Brain-specific homeobox_POU domain protein 4,Brn4,Brn-4,Brn-4,Mouse,Mus musculus,Oct-9,Octamer-binding protein 9,Octamer-binding transcription factor 9,Otf9,OTF-9,POU domain, class 96T
E1643m ELISA Brain-4,Brain-specific homeobox_POU domain protein 4,Brn4,Brn-4,Brn-4,Mouse,Mus musculus,Oct-9,Octamer-binding protein 9,Octamer-binding transcription factor 9,Otf9,OTF-9,POU domain, class 3, tr 96T
U1616m CLIA Brain-1,Brain-specific homeobox_POU domain protein 1,Brn1,Brn-1,Brn-1,Mouse,Mus musculus,Oct-8,Octamer-binding protein 8,Octamer-binding transcription factor 8,Otf8,OTF-8,POU domain, class 3, tra 96T
E1616m ELISA Brain-1,Brain-specific homeobox_POU domain protein 1,Brn1,Brn-1,Brn-1,Mouse,Mus musculus,Oct-8,Octamer-binding protein 8,Octamer-binding transcription factor 8,Otf8,OTF-8,POU domain, class 3, tr 96T
U1643m CLIA Brain-4,Brain-specific homeobox_POU domain protein 4,Brn4,Brn-4,Brn-4,Mouse,Mus musculus,Oct-9,Octamer-binding protein 9,Octamer-binding transcription factor 9,Otf9,OTF-9,POU domain, class 3, tra 96T
U1533h CLIA Homo sapiens,Human,OCT3,Oct-3,OCT4,Oct-4,Octamer-binding protein 3,Octamer-binding protein 4,Octamer-binding transcription factor 3,OTF3,OTF-3,POU domain, class 5, transcription factor 1,POU5F1 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur